NCT01244867 Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine Status COMPLETED Phase PHASE2
NCT01143064 Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury Status COMPLETED Phase PHASE3
NCT01058538 A Dose Finding Pharmacokinetic Study of the Tumour-targeting Human L19IL2 Monoclonal Antibody-Cytokine Fusion Protein in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1/PHASE2
NCT01035502 A Study of Elacytarabine (CP-4055) Plus Idarubicin as Second Course Remission-Induction Therapy in Patients With Acute Myeloid Leukaemia Status COMPLETED Phase PHASE2
NCT01034748 A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT00968851 Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT00766363 Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00735683 A Short-Term Study to Examine the Effects of ATHX-105 Phosphate on Weight Loss and Safety Status WITHDRAWN Phase PHASE2
NCT00609544 Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia Status WITHDRAWN Phase PHASE2
NCT00595231 Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD) Status COMPLETED Phase PHASE2
NCT00573443 Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS Status COMPLETED Phase PHASE3
NCT00520780 Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF) Status COMPLETED Phase PHASE3
NCT00491998 PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets Status COMPLETED Phase PHASE1/PHASE2
NCT00404989 Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. Status RECRUITING Phase N/A
NCT00358566 GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer Status TERMINATED Phase PHASE3
NCT00283361 ZP120 Add-on to Furosemide in Treatment of Acute or Sub-Acute Decompensated Heart Failure Status TERMINATED Phase PHASE2